Brief: Avalon Globocare Achieves Milestones In Advancing Novel Intranasal And Oral Covid-19 Vaccine Candidate

Change Agents

25/06/2020 14:29

June 25 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE ACHIEVES MILESTONES IN ADVANCING NOVEL
INTRANASAL AND ORAL COVID-19 VACCINE CANDIDATE
    * AVALON GLOBOCARE -  PARTNERSHIP WITH UNIVERSITY OF NATURAL
RESOURCES AND LIFE SCIENCES IN VIENNA, AUSTRIA
    * AVALON GLOBOCARE -  PARTNERSHIP TO DEVELOP AN S-LAYER
VACCINE
THAT CAN BE ADMINISTERED BY AN INTRANASAL OR ORAL ROUTE AGAINST
SARS-COV-2

Source text for Eikon:  ID:nGNX3vdDXQ 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))